<?xml version="1.0" encoding="UTF-8"?>
<p>Triterpenoid toosendanin (TSN) is a main bioactive component of fruits and bark of traditional anthelmintic and insecticidal plants 
 <italic>Melia azedarach</italic> and 
 <italic>Melia toosendan</italic>. Toosendanin has antibotulinum (inhibits the botulinum neurotoxin interaction with the SNARE protein), anti-influenza (alters nuclear localization of viral polymerase PA protein), anticancer, anti-inflammatory, and analgesic (selective presynaptic blocker) efficacy [
 <xref rid="B310-microorganisms-09-00197" ref-type="bibr">310</xref>,
 <xref rid="B311-microorganisms-09-00197" ref-type="bibr">311</xref>]. Possible actions of TSN as an antitumor drug against a variety of cancer types involve inhibition of STAT3, an emerging target for cancer therapy, induction of estrogen receptor β (ERβ) and p53 proteins, and activation of the mitochondrial apoptotic pathway [
 <xref rid="B312-microorganisms-09-00197" ref-type="bibr">312</xref>,
 <xref rid="B313-microorganisms-09-00197" ref-type="bibr">313</xref>,
 <xref rid="B314-microorganisms-09-00197" ref-type="bibr">314</xref>]. Three unidentified endophytic fungal strains in 
 <italic>M</italic>. 
 <italic>azedarach</italic> have been reported to produce toosendanin [
 <xref rid="B291-microorganisms-09-00197" ref-type="bibr">291</xref>,
 <xref rid="B292-microorganisms-09-00197" ref-type="bibr">292</xref>].
</p>
